Fudosteine
Impurities
- Fudosteine is a derivative of cysteine developed and approved in Japan for the treatment of such diseases as bronchial asthma, chronic bronchitis, pulmonary emphysema, bronchiectasis, pulmonary tuberculosis, pneumoconiosis, atypical mycobacterial disease, and diffuse panbronchiolitis. Reference standards of Fudosteine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Fudosteine
[catalogue_number] => PA 06 1450000
[category_ids] => ,97,78,75,76,82,
[chemical_name] =>
[weight] => 179.23
[form] => C6H13NO3S
[cas] => 13189-98-5
[pslug] => 13189-98-5-fudosteine-pa061450000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 06 1450000
Molecular Formula : C6H13NO3S
Molecular Weight : 179.23
stdClass Object
(
[pname] => S-(3-(3-Chloropropoxy)propyl)-L-cysteine
[catalogue_number] => PA 06 1451000
[category_ids] => ,78,75,76,82,
[chemical_name] =>
[weight] => 255.76
[form] => C9H18ClNO3S
[cas] => NA
[pslug] => -s-3-3-chloropropoxy-propyl-l-cysteine-pa061451000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
S-(3-(3-Chloropropoxy)propyl)-L-cysteine
Catalogue No.:PA 06 1451000
Molecular Formula : C9H18ClNO3S
Molecular Weight : 255.76
